Brief: Fortrea Completes Divestiture Of Endpoint Clinical, Patient Access Businesses To Arsenal Capital Partners
04/06/2024 12:54
June 4 (Reuters) - Fortrea Holdings Inc FTRE.O :
* FORTREA COMPLETES DIVESTITURE OF ENDPOINT CLINICAL AND
PATIENT
ACCESS BUSINESSES TO ARSENAL CAPITAL PARTNERS
Source text for Eikon: ID:nGNX8G4RrH
Further company coverage: FTRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortrea Holdings
See all newsFortrea Q3 revenue beats expectations on bookings momentum, guidance raised
Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Brief: Fortrea Completes Acquisition Of The Early Phase Services Division From Worldwide Clinical Trials
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike